Blood tests for colorectal cancer—Hype ahead of evidence?
G
Gloria D. Coronado
(Department of Epidemiology and Biostatistics Mel and Enid Zuckerman School of Public Health University of Arizona Tucson Arizona USA)
D
David A. Lieberman
(Division of Gastroenterology and Hepatology Oregon Health and Science University Portland Oregon USA)
Article Details
Volume / Issue
Vol. 76, Issue 3
Published
May 01, 2026
ISSN
0007-9235
Publisher
Wiley
Authors (2)
G
Gloria D. Coronado
Department of Epidemiology and Biostatistics Mel and Enid Zuckerman School of Public Health University of Arizona Tucson Arizona USA
D
David A. Lieberman
Division of Gastroenterology and Hepatology Oregon Health and Science University Portland Oregon USA
Related Articles from this Journal
Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates
Xia Wu, Heather Landau et al.
May 2026
10.3322/caac.70092
Screening for colorectal cancer
May 2026
10.3322/caac.70087
Correction to “Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases”
May 2026
10.3322/caac.70093
Medullary thyroid carcinoma and <i>RET</i> molecular testing: A virtual tumor board on clinical decision‐making
Lucas Kallas‐Silva, Victor Alexandre dos Santos Valsecchi et al.
May 2026
10.3322/caac.70086
Colorectal cancer screening: An update to the American Cancer Society guideline, 2026
Andrew M. D. Wolf, Richard M. Hoffman et al.
May 2026
10.3322/caac.70083